BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1475815)

  • 41. Morphology Of Bone Marrow In Visceral Leishmaniasis.
    Idris M; Farid J; Gul N
    J Ayub Med Coll Abbottabad; 2018; 30(3):342-344. PubMed ID: 30465362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of PCR with stained slides of bone marrow and lymph nodes aspirates with suspect diagnosis for leishmaniasis.
    Santos TR; Carreira VS; Ferrari HF; Moreira MA; Luvizotto MC
    Acta Trop; 2014 Dec; 140():137-40. PubMed ID: 25159534
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Challenges in the diagnosis of post kala-azar dermal leishmaniasis.
    Salotra P; Singh R
    Indian J Med Res; 2006 Mar; 123(3):295-310. PubMed ID: 16778312
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of latex agglutination test (KAtex) for early diagnosis of kala-azar.
    Ahsan MM; Islam MN; Mollah AH; Hoque MA; Hossain MA; Begum Z; Islam MT
    Mymensingh Med J; 2010 Jul; 19(3):335-9. PubMed ID: 20639822
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A new strategy for elimination of kala-azar from rural Bihar.
    Thakur CP
    Indian J Med Res; 2007 Nov; 126(5):447-51. PubMed ID: 18160749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reactivity of various leishmanial antigens in a direct agglutination test and their value in differentiating post-kala azar dermal leishmaniasis from leprosy and other skin conditions.
    El Harith A; Chowdhury S; Al-Masum A; Semião-Santos S; Das PK; Akhter S; Vetter JC; Haq I
    J Med Microbiol; 1996 Feb; 44(2):141-6. PubMed ID: 8642576
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sensitive and less invasive confirmatory diagnosis of visceral leishmaniasis in Sudan using loop-mediated isothermal amplification (LAMP).
    Mukhtar M; Ali SS; Boshara SA; Albertini A; Monnerat S; Bessell P; Mori Y; Kubota Y; Ndung'u JM; Cruz I
    PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006264. PubMed ID: 29444079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A comparative study of the effectiveness of diagnostic tests for visceral leishmaniasis.
    Boelaert M; Rijal S; Regmi S; Singh R; Karki B; Jacquet D; Chappuis F; Campino L; Desjeux P; Le Ray D; Koirala S; Van der Stuyft P
    Am J Trop Med Hyg; 2004 Jan; 70(1):72-7. PubMed ID: 14971701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Leishmaniasis with cutaneous and visceral involvement in a 13-month old boy].
    Landmann E; Bogdan C; Donhauser N; Artlich A; Staude B; Gortner L
    Klin Padiatr; 2000; 212(5):266-7. PubMed ID: 11048286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Evaluation of a rapid immunochromatographic test for diagnosis of kala-azar & post kala-azar dermal leishmaniasis at a tertiary care centre of north India.
    Mathur P; Samantaray J; Chauhan NK
    Indian J Med Res; 2005 Dec; 122(6):485-90. PubMed ID: 16517998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study.
    Sundar S; Singh RK; Bimal SK; Gidwani K; Mishra A; Maurya R; Singh SK; Manandhar KD; Boelaert M; Rai M
    Trop Med Int Health; 2007 Feb; 12(2):284-9. PubMed ID: 17300637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Case report: the efficacy of amphotericin B in visceral leishmaniasis].
    Güleç SG; Kizilyer Y; Karaman S; Erdem E; Urganci N
    Turkiye Parazitol Derg; 2010; 34(2):73-5. PubMed ID: 20597048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dynamics of the antibodies in cohorts of cured cases of visceral leishmaniasis: its implication on the validity of serological test, value in prognosis and in post therapeutic assessment.
    Patil RR; Muliyil JP; Nandy A; Addy A; Maji AK; Chatterjee P
    Hum Vaccin Immunother; 2012 Jun; 8(6):725-30. PubMed ID: 22495122
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of the use of a rapid diagnostic test for visceral leishmaniasis on clinical practice in Ethiopia: a retrospective study.
    Diro E; Lynen L; Assefa M; Takele Y; Mengesha B; Adem E; Mohammed R; Kimutai R; Hailu A; Boelaert M; van Griensven J
    PLoS Negl Trop Dis; 2015 May; 9(5):e0003738. PubMed ID: 25965564
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Visceral kala-azar of Spanish origin. Apropos of a case].
    De Caluwé JP; Lievens P; Trolin C; Heimann R; Delcourt A; Taelman H
    Acta Clin Belg; 1988; 43(5):349-55. PubMed ID: 3061269
    [No Abstract]   [Full Text] [Related]  

  • 56. Liver-spleen scintiscan in kala-azar: case report.
    Maniot AL
    J Nucl Med; 1975 Dec; 16(12):1128-9. PubMed ID: 1194960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Visceral leishmaniasis (kala azar) in a patient with AIDS.
    Smith D; Gazzard B; Lindley RP; Darwish A; Reed C; Bryceson AD; Evans DA
    AIDS; 1989 Jan; 3(1):41-3. PubMed ID: 2496712
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A case of kala-azar diagnosed by bone marrow aspiration.
    Hamidah NH; Cheong SK; Abu Hassan J
    Malays J Pathol; 1995 Jun; 17(1):39-41. PubMed ID: 8907004
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of direct agglutination test, rk39 Test, and ELISA for the diagnosis of visceral leishmaniasis.
    Mandal J; Khurana S; Dubey ML; Bhatia P; Varma N; Malla N
    Am J Trop Med Hyg; 2008 Jul; 79(1):76-8. PubMed ID: 18606766
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Potential of direct agglutination test based on promastigote and amastigote antigens for serodiagnosis of post-kala-azar dermal leishmaniasis.
    Singh R; Subba Raju BV; Jain RK; Salotra P
    Clin Diagn Lab Immunol; 2005 Oct; 12(10):1191-4. PubMed ID: 16210482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.